Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Q3 Revenues up Sharply

NEW YORK (GenomeWeb) – GeneNews today said that its revenues for the third quarter rose around 30-fold year over year.

The Toronto-based molecular diagnostics firm reported total revenues of C$1.1 million (US$973,000) for the three months ended Sept. 30, up from C$37,002 in Q3 2013, according to a regulatory document. All revenues for the recently completed quarter were derived from royalties. In the year-ago period, GeneNews had no royalties.

The firm said it had no milestone revenues for Q3 2014 compared to C$36,060 in the year-ago period, and no test revenues for the recently completed quarter, down from C$942 a year ago.

The company cut its net loss to C$893,407, or C$.02 per share, in Q3 2014, from a net loss of C$3.4 million, or C$.10 per share, a year ago.

GeneNews had no R&D costs for the third quarter, compared to C$490,720 a year ago. It trimmed its SG&A expenses 7 percent to C$933,751 from C$1.0 million.

The company exited the quarter with C$4.4 million in cash and cash equivalents.

During the summer of 2013, GeneNews, Health Diagnostic Laboratory, and an unnamed sales organization formed a joint venture called Innovative Diagnostic Laboratory. GeneNews said today that IDL had revenues of about C$4.7 million for the third quarter and costs of C$8.1 million, resulting in a loss of C$3.4 million.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.